SpringSource: Eating, Weight & Mood Disorders provides specialized eating disorder therapy and GLP-1 mental health support in Chicago and Northbrook, with virtual care available throughout Illinois
Bates HE et al (2012) Gipr is essential for adrenocortical steroidogenesis
An observational study published in 2023 in Diabetes Care that looked to determine whether the use of GLP-1 medications was associated with an increased risk of thyroid cancer found that in 1-3 years of treatment, the risk for thyroid cancer was increased for those taking GLP-1 medications (2)
GLP-1 receptor agonists the drug class behind weight-management medicines such as semaglutide work by enhancing satiety and slowing gastric emptying, which reduces appetite and food intake
If you're tired of relying on willpower alone, want to reduce cravings scientifically, or are simply curious whether naltrexone could help you quit drinking, professional assessment is the first step